Drug profile

The FDA adverse-event record for Canine Adenovirus Type 2,Toronto A/26/61,Live + Canine Distemper,Vcp258,Vector + Canine Parvovirus,780916,Live

29 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Canine Adenovirus Type 2,Toronto A/26/61,Live + Canine Distemper,Vcp258,Vector + Canine Parvovirus,780916,Live. See the species affected, top reactions, and outcomes below.

29
adverse-event reports
3.4%
death-coded share
Dog
most-reported species
12
Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
29
Total Reports
1
Deaths Reported
3.4%
Death Rate

Active Ingredients

Canine Adenovirus Type 2,Toronto A/26/61,LiveCanine Distemper,Vcp258,VectorCanine Parvovirus,780916,Live

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 29

Most Affected Breeds

Chihuahua 3
Retriever - Golden 3
Pit Bull 2
Spitz - German Pomeranian 2
Terrier - Jack Russell 2
Corgi - Welsh Cardigan 1
Boxer (German Boxer) 1
Shiba Inu 1
Spitz - American Eskimo Dog 1
Maltese 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 12
Vomiting 9
Injection site pain 5
Behavioural disorder NOS 4
Injection site swelling 4
Vocalisation 4
Lameness 3
Not eating 3
Injection site lump 2
Injection site abscess 2
Diarrhoea 2
Decreased appetite 2

Outcome Breakdown

Outcome Unknown
15 (51.7%)
Recovered/Normal
13 (44.8%)
Died
1 (3.4%)

Canine Adenovirus Type 2,Toronto A/26/61,Live + Canine Distemper,Vcp258,Vector + Canine Parvovirus,780916,Live Adverse Event Insights

29 reports name Canine Adenovirus Type 2,Toronto A/26/61,Live + Canine Distemper,Vcp258,Vector + Canine Parvovirus,780916,Live; 1 recorded a death outcome (3.4% of reported events, not a population-level mortality rate). Active ingredients: Canine Adenovirus Type 2,Toronto A/26/61,Live, Canine Distemper,Vcp258,Vector, Canine Parvovirus,780916,Live. Administration routes: Subcutaneous, Unknown.

By species: Dog (29 reports). By breed: Chihuahua (3), Retriever - Golden (3), Pit Bull (2).

Leading clinical signs: Lethargy (see also Central nervous system depression in 'Neurological') (12), Vomiting (9), Injection site pain (5), Behavioural disorder NOS (4). Outcome, 29 coded reports: Outcome Unknown leads at 51.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.